author_facet Wender, Richard C.
Brawley, Otis W.
Fedewa, Stacey A.
Gansler, Ted
Smith, Robert A.
Wender, Richard C.
Brawley, Otis W.
Fedewa, Stacey A.
Gansler, Ted
Smith, Robert A.
author Wender, Richard C.
Brawley, Otis W.
Fedewa, Stacey A.
Gansler, Ted
Smith, Robert A.
spellingShingle Wender, Richard C.
Brawley, Otis W.
Fedewa, Stacey A.
Gansler, Ted
Smith, Robert A.
CA: A Cancer Journal for Clinicians
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
Oncology
Hematology
author_sort wender, richard c.
spelling Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21550 <jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p> A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control CA: A Cancer Journal for Clinicians
doi_str_mv 10.3322/caac.21550
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTUw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTUw
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
imprint Wiley, 2019
imprint_str_mv Wiley, 2019
issn 0007-9235
1542-4863
issn_str_mv 0007-9235
1542-4863
language English
mega_collection Wiley (CrossRef)
match_str wender2019ablueprintforcancerscreeningandearlydetectionadvancingscreeningscontributiontocancercontrol
publishDateSort 2019
publisher Wiley
recordtype ai
record_format ai
series CA: A Cancer Journal for Clinicians
source_id 49
title A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_unstemmed A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_full A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_fullStr A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_full_unstemmed A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_short A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_sort a blueprint for cancer screening and early detection: advancing screening’s contribution to cancer control
topic Oncology
Hematology
url http://dx.doi.org/10.3322/caac.21550
publishDate 2019
physical 50-79
description <jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p>
container_issue 1
container_start_page 50
container_title CA: A Cancer Journal for Clinicians
container_volume 69
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792346186369204233
geogr_code not assigned
last_indexed 2024-03-01T17:35:23.047Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+blueprint+for+cancer+screening+and+early+detection%3A+Advancing+screening%E2%80%99s+contribution+to+cancer+control&rft.date=2019-01-01&genre=article&issn=1542-4863&volume=69&issue=1&spage=50&epage=79&pages=50-79&jtitle=CA%3A+A+Cancer+Journal+for+Clinicians&atitle=A+blueprint+for+cancer+screening+and+early+detection%3A+Advancing+screening%E2%80%99s+contribution+to+cancer+control&aulast=Smith&aufirst=Robert+A.&rft_id=info%3Adoi%2F10.3322%2Fcaac.21550&rft.language%5B0%5D=eng
SOLR
_version_ 1792346186369204233
author Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A.
author_facet Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A., Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A.
author_sort wender, richard c.
container_issue 1
container_start_page 50
container_title CA: A Cancer Journal for Clinicians
container_volume 69
description <jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p>
doi_str_mv 10.3322/caac.21550
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTUw
imprint Wiley, 2019
imprint_str_mv Wiley, 2019
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229
issn 0007-9235, 1542-4863
issn_str_mv 0007-9235, 1542-4863
language English
last_indexed 2024-03-01T17:35:23.047Z
match_str wender2019ablueprintforcancerscreeningandearlydetectionadvancingscreeningscontributiontocancercontrol
mega_collection Wiley (CrossRef)
physical 50-79
publishDate 2019
publishDateSort 2019
publisher Wiley
record_format ai
recordtype ai
series CA: A Cancer Journal for Clinicians
source_id 49
spelling Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21550 <jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p> A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control CA: A Cancer Journal for Clinicians
spellingShingle Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A., CA: A Cancer Journal for Clinicians, A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control, Oncology, Hematology
title A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_full A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_fullStr A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_full_unstemmed A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_short A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
title_sort a blueprint for cancer screening and early detection: advancing screening’s contribution to cancer control
title_unstemmed A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
topic Oncology, Hematology
url http://dx.doi.org/10.3322/caac.21550